Literature DB >> 22728043

TNFα enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells.

Sung Hee Lee1, Hannah S Hong, Zi Xiao Liu, Reuben H Kim, Mo K Kang, No-Hee Park, Ki-Hyuk Shin.   

Abstract

Cancer stem-like cell (CSC; also known as tumor initiating cell) is defined as a small subpopulation of cancer cells within a tumor and isolated from various primary tumors and cancer cell lines. CSCs are highly tumorigenic and resistant to anticancer treatments. In this study, we found that prolonged exposure to tumor necrosis factor alpha (TNFα), a major proinflammatory cytokine, enhances CSC phenotype of oral squamous cell carcinoma (OSCC) cells, such as an increase in tumor sphere-forming ability, stem cell-associated genes expression, chemo-radioresistance, and tumorigenicity. Moreover, activation of Notch1 signaling was detected in the TNFα-exposed cells, and suppression of Notch1 signaling inhibited CSC phenotype. Furthermore, we demonstrated that inhibition of a Notch downstream target, Hes1, led to suppression of CSC phenotype in the TNFα-exposed cells. We also found that Hes1 expression is commonly upregulated in OSCC lesions compared to precancerous dysplastic lesions, suggesting the possible involvement of Hes1 in OSCC progression and CSC in vivo. In conclusion, inflammatory cytokine exposure may enhance CSC phenotype of OSCC, in part by activating the Notch-Hes1 pathway. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22728043      PMCID: PMC3488595          DOI: 10.1016/j.bbrc.2012.06.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

Review 1.  Advances in the diagnosis of oral premalignant and malignant lesions.

Authors:  Joel B Epstein; Lewei Zhang; Miriam Rosin
Journal:  J Can Dent Assoc       Date:  2002-11       Impact factor: 1.316

Review 2.  Stem cells in squamous head and neck cancer.

Authors:  Andreas E Albers; Chao Chen; Beate Köberle; Xu Qian; Jens P Klussmann; Barbara Wollenberg; Andreas M Kaufmann
Journal:  Crit Rev Oncol Hematol       Date:  2011-04-20       Impact factor: 6.312

Review 3.  The bHLH gene Hes1 regulates differentiation of multiple cell types.

Authors:  R Kageyama; T Ohtsuka; K Tomita
Journal:  Mol Cells       Date:  2000-02-29       Impact factor: 5.034

Review 4.  Conversion of normal to malignant phenotype: telomere shortening, telomerase activation, and genomic instability during immortalization of human oral keratinocytes.

Authors:  M K Kang; N H Park
Journal:  Crit Rev Oral Biol Med       Date:  2001

5.  Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression.

Authors:  Jun-Li Luo; Shin Maeda; Li-Chung Hsu; Hideo Yagita; Michael Karin
Journal:  Cancer Cell       Date:  2004-09       Impact factor: 31.743

6.  Tumor necrosis factor alpha induces senescence and chromosomal instability in human leukemic cells.

Authors:  Odile Beyne-Rauzy; Christian Recher; Nicole Dastugue; Cécile Demur; Géraldine Pottier; Guy Laurent; Laure Sabatier; Véronique Mansat-De Mas
Journal:  Oncogene       Date:  2004-09-30       Impact factor: 9.867

7.  NF-kappaB functions as a tumour promoter in inflammation-associated cancer.

Authors:  Eli Pikarsky; Rinnat M Porat; Ilan Stein; Rinat Abramovitch; Sharon Amit; Shafika Kasem; Elena Gutkovich-Pyest; Simcha Urieli-Shoval; Eithan Galun; Yinon Ben-Neriah
Journal:  Nature       Date:  2004-08-25       Impact factor: 49.962

Review 8.  Caught up in a Wnt storm: Wnt signaling in cancer.

Authors:  Rachel H Giles; Johan H van Es; Hans Clevers
Journal:  Biochim Biophys Acta       Date:  2003-06-05

Review 9.  Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

Authors:  Peter W Szlosarek; Frances R Balkwill
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

10.  An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors.

Authors:  Kate A Scott; Robert J Moore; Caroline H Arnott; Nick East; Richard G Thompson; Bernard J Scallon; David J Shealy; Frances R Balkwill
Journal:  Mol Cancer Ther       Date:  2003-05       Impact factor: 6.261

View more
  44 in total

Review 1.  Hes1: a key role in stemness, metastasis and multidrug resistance.

Authors:  Zi-Hao Liu; Xiao-Meng Dai; Bin Du
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

2.  The NOTCH4-HEY1 Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.

Authors:  Takahito Fukusumi; Theresa W Guo; Akihiro Sakai; Mizuo Ando; Shuling Ren; Sunny Haft; Chao Liu; Panomwat Amornphimoltham; J Silvio Gutkind; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2017-11-16       Impact factor: 12.531

Review 3.  Targeting cancer stem cell pathways for cancer therapy.

Authors:  Liqun Yang; Pengfei Shi; Gaichao Zhao; Jie Xu; Wen Peng; Jiayi Zhang; Guanghui Zhang; Xiaowen Wang; Zhen Dong; Fei Chen; Hongjuan Cui
Journal:  Signal Transduct Target Ther       Date:  2020-02-07

4.  HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

Authors:  Hang Wang; Miqing Yang; Ling Lin; Hongzhen Ren; Chaotong Lin; Suling Lin; Guoying Shen; Binfeng Ji; Chun Meng
Journal:  Cell Oncol (Dordr)       Date:  2015-12-09       Impact factor: 6.730

5.  Inflammation-mediated notch signaling skews fanconi anemia hematopoietic stem cell differentiation.

Authors:  Wei Du; Surya Amarachintha; Jared Sipple; Jonathan Schick; Kris Steinbrecher; Qishen Pang
Journal:  J Immunol       Date:  2013-08-07       Impact factor: 5.422

6.  Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.

Authors:  Chang-Ryul Lee; Sung Hee Lee; Nicole Kristina Rigas; Reuben H Kim; Mo K Kang; No-Hee Park; Ki-Hyuk Shin
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

Review 7.  The NOTCH Pathway in Head and Neck Squamous Cell Carcinoma.

Authors:  T Fukusumi; J A Califano
Journal:  J Dent Res       Date:  2018-02-28       Impact factor: 6.116

8.  Honokiol as a Radiosensitizing Agent for Colorectal cancers.

Authors:  Zhiyun He; Dharmalingam Subramaniam; Zhongtao Zhang; Youcheng Zhang; Shrikant Anant
Journal:  Curr Colorectal Cancer Rep       Date:  2013-12

9.  Diabetes-associated dysregulated cytokines and cancer.

Authors:  Yong Wu; Yanjun Liu; Yunzhou Dong; Jay Vadgama
Journal:  Integr Cancer Sci Ther       Date:  2016-02-15

Review 10.  Interplay between inflammatory tumor microenvironment and cancer stem cells.

Authors:  Shijian Zhang; Xi Yang; Lei Wang; Chenping Zhang
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.